Get the Stockscreener App
1.87
3.31%
0.06
Creative Medical Technology Holdings Inc stock is traded at $1.87, with a volume of 22,227.
It is up +3.31% in the last 24 hours and up +1.08% over the past month.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
See More
Previous Close:
$1.81
Open:
$1.82
24h Volume:
22,227
Relative Volume:
0.32
Market Cap:
$6.54M
Revenue:
$6,000
Net Income/Loss:
$-5.96M
P/E Ratio:
-0.6433
EPS:
-2.9067
Net Cash Flow:
$-5.87M
1W Performance:
-0.53%
1M Performance:
+1.08%
6M Performance:
-42.46%
1Y Performance:
-15.00%
1-Day Range:
$1.81
$1.96
1-Week Range:
$1.78
$1.97
52-Week Range:
$1.504
$6.25
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Name
Creative Medical Technology Holdings Inc
Sector
Industry
Phone
480-399-2822
Address
211 E. OSBORN RD., PHOENIX
Compare CELZ vs VRTX, REGN, ALNY, ARGX, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
1.87 | 6.33M | 6,000 | -5.96M | -5.87M | -2.9067 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Creative Medical Technology Holdings Inc Stock (CELZ) Latest News
Rate Cut: Is Creative Medical Technology Holdings Inc stock risky to hold nowMarket Rally & Expert Verified Movement Alerts - baoquankhu1.vn
Growth Review: What is Creative Medical Technology Holdings Incs 5 year growth outlook2026 Top Decliners & Real-Time Price Movement Reports - baoquankhu1.vn
Form 10-KAnnual Reports - Stock Titan
If You Invested $1,000 in Creative Med Technology Hldgs (CELZ) - Stock Titan
Aug Rallies: What is Creative Medical Technology Holdings Incs 5 year growth outlook2026 Sector Moves & Real-Time Volume Trigger Notifications - baoquankhu1.vn
BMRA PE Ratio & Valuation, Is BMRA Overvalued - Intellectia AI
Aug Weekly: Is Creative Medical Technology Holdings Inc. a strong candidate for buy and hold2026 Setups & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Creative Medical Technologies Holdings, Inc. 2025 Annual Report: Regenerative Stem Cell Therapies, Clinical Trials, and Intellectual Property Portfolio 151926293035 - Minichart
Creative Medical (NASDAQ: CELZ) details 2025 losses and regenerative trial progress - Stock Titan
Creative Medical Technology Holdings 10-K: Revenue $0.006M, EPS $(2.52) - TradingView
Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
CELZ Earnings History & Surprises | EPS & Revenue Results | CREATIVE MEDICAL TECHNOLOGY (NASDAQ:CELZ) - ChartMill
Aug Analyst Calls: What is Creative Medical Technology Holdings Incs book value per shareFed Meeting & Weekly Top Performers Watchlists - baoquankhu1.vn
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials - balticbusinessnews.com
Buybacks Report: What is Creative Medical Technology Holdings Incs book value per shareMarket Activity Summary & High Return Trade Guides - baoquankhu1.vn
Sentiment Recap: What hedge funds are buying Creative Medical Technology Holdings Inc2026 Dividend Review & Real-Time Buy Signal Notifications - baoquankhu1.vn
Aug Big Picture: Can Bridger Aerospace Group Holdings Inc Equity Warrant weather a recession - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Risk Recap: Is Calumet Inc impacted by rising rates2026 Short Interest & Smart Allocation Stock Reports - baoquankhu1.vn
EY USHome | Building a better working world - EY
Risk Analysis: Does Creative Medical Technology Holdings Inc have a competitive edge2026 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Retail Traders Pile Into Creative Medical After FDA Fast Tracks Degenerative Disc Disease Therapy - MSN
Shareholders reelect directors and approve governance proposals - MSN
Will iCAD Inc. stock beat EPS estimates2026 Volatility Report & Growth Oriented Trade Recommendations - Naître et grandir
Buyback Watch: Will Creative Medical Technology Holdings Inc outperform during market rallies2025 Growth vs Value & Fast Moving Stock Watchlists - baoquankhu1.vn
Fed Watch: Why is On Holding AG stock going downMarket Risk Report & Community Supported Trade Ideas - baoquankhu1.vn
Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday - Defense World
Creative Medical Technology (NASDAQ:CELZ) Stock Passes Below Fifty Day Moving Average – Time to Sell? - Defense World
The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them (2026-03-03) - Seeking Alpha
Swing Trade: What hedge funds are buying Creative Medical Technology Holdings Inc2025 Growth vs Value & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
CELZ Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TIRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Weekly Recap: Will Creative Medical Technology Holdings Inc outperform during market ralliesShare Buyback & Expert Approved Trade Ideas - baoquankhu1.vn
Envestnet Asset Management Inc. Buys 4,449 Shares of Teleflex Incorporated $TFX - Defense World
April Boyce Joins PetVivo Holdings, Inc. as the Vice President of Marketing - Quantisnow
What is Creative Medical Technology Holdings Inc. s 5 year growth outlookJuly 2025 Big Picture & High Conviction Investment Ideas - mfd.ru
Alphabet, Inc. | History, Products, & Business Segments | Britannica Money - Britannica
Exosome Research Market Global Forecast Report 2026-2032: - GlobeNewswire
Exosome Research Market Global Forecast Report 2026-2032: Opportunities Driven by Advancing Precision Medicine, Next Generation Diagnostics, and New Biomedical Applications - Yahoo Finance UK
Gains Report: Is Visteon Corporation currently under institutional pressureInflation Watch & Stepwise Trade Execution Plans - baoquankhu1.vn
Is Creative Medical Technology Holdings Inc. a strong candidate for buy and holdJuly 2025 Final Week & High Conviction Investment Ideas - mfd.ru
Can Creative Medical Technology Holdings Inc. continue delivering strong returnsWeekly Investment Report & Accurate Intraday Trade Tips - mfd.ru
How Lumen Technologies Inc. stock reacts to inflationary pressures - mfd.ru
Can Creative Medical Technology Holdings Inc. stock sustain institutional interestMarket Performance Summary & Consistent Return Strategy Ideas - mfd.ru
Will Robinhood Markets Inc. announce a stock splitExit Point & AI Forecasted Entry and Exit Points - mfd.ru
CELZ Should I Buy - Intellectia AI
Will Creative Medical Technology Holdings Inc. stock hit new highs in YEAR2025 Bull vs Bear & Safe Capital Growth Stock Tips - mfd.ru
How liquid is Creative Medical Technology Holdings Inc. stock2025 Top Decliners & Fast Exit/Entry Strategy Plans - mfd.ru
Creative Medical receives WHO designation for second cell therapy By Investing.com - Investing.com South Africa
Creative Medical receives WHO designation for second cell therapy - Investing.com Nigeria
Creative Medical Technology Holdings Inc Stock (CELZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):